Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Merck (MRK) Q2 2026 Earnings Call Transcript

Summary by The Motley Fool
Oncology and animal health drove $16.6B revenue growth amid upcoming patent expirations.

3 Articles

The Motley FoolThe Motley Fool
Lean Left

Merck (MRK) Q2 2026 Earnings Call Transcript

Oncology and animal health drove $16.6B revenue growth amid upcoming patent expirations.

·Alexandria, United States
Read Full Article
analytica-world.comanalytica-world.com
Reposted by
bionity.combionity.com

Merck Raises Annual Forecast and Expects Sales of up to € 21.8 Billion

Merck announced its business figures for the second quarter of 2026. The company achieved a robust result and increased its forecast for the full year. Group sales increased organically by 4.1 % compared to the previous year's quarter to € 5.4 billion (Q2 2025: € 5.3 billion).

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

bionity.com broke the news on Monday, August 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Merck icon

Merck

Hesse icon

Hesse

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal